ECOR
Electrocore LLC
NASDAQ: ECOR · HEALTHCARE · MEDICAL DEVICES
$6.51
+5.85% today
Updated 2026-04-30
Market cap
$49.92M
P/E ratio
—
P/S ratio
1.56x
EPS (TTM)
$-1.65
Dividend yield
—
52W range
$4 – $9
Volume
0.1M
Electrocore LLC (ECOR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-13.23M | $-25.33M | $-47.11M | $-45.07M | $-20.05M | $-13.63M | $-16.64M | $-14.67M | $-6.95M | $-8.19M |
| Capital expenditures | $152526.00 | $152526.00 | $278921.00 | $69675.00 | $0.00 | $0.00 | $0.00 | $206000.00 | $0.00 | $66000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $142583.00 | $462329.00 | $7.60M | $3.90M | $3.27M | $3.30M | $2.68M | $1.70M | $1.87M | $1.93M |
| Free cash flow | $-13.38M | $-25.48M | $-47.39M | $-45.14M | $-20.05M | $-13.63M | $-16.64M | $-14.87M | $-6.95M | $-8.25M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $3.63B | — | — | — | $0.00 | $0.00 | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $-5.62M | $6.07M | $-9.11M | — | — | — | — | — |